Naruhiko Mizuta
- Co-authors
- Ikuya FujiwaraHiroo NakajimaSatoru HashimotoYoshihiro KitamuraKoichi SakaguchiKunihiko KooguchiAtsuko KobayashiJunji Magae
- Topics
- Breast Cancer Treatment Studies (13 papers)Cell death mechanisms and regulation (9 papers)Breast Implant and Reconstruction (9 papers)
- Journals
- Journal of Clinical OncologyAmerican Journal of Respiratory and Critical Care MedicineOncogene
- Partner nations
- JapanSouth KoreaUnited States
In The Last Decade
Naruhiko Mizuta
42 papers receiving 670 citations
Peers
Comparison fields: 5 of 83
- Molecular Biology 252
- Surgery 187
- Cancer Research 169
- Immunology 157
- Pulmonary and Respiratory Medicine 143
Countries citing papers authored by Naruhiko Mizuta
This map shows the geographic impact of Naruhiko Mizuta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naruhiko Mizuta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naruhiko Mizuta more than expected).
Fields of papers citing papers by Naruhiko Mizuta
This network shows the impact of papers produced by Naruhiko Mizuta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naruhiko Mizuta. The network helps show where Naruhiko Mizuta may publish in the future.
Co-authorship network of co-authors of Naruhiko Mizuta
This figure shows the co-authorship network connecting the top 25 collaborators of Naruhiko Mizuta. A scholar is included among the top collaborators of Naruhiko Mizuta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naruhiko Mizuta. Naruhiko Mizuta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | [A case of effective combination therapy with docetaxel, cyclophosphamide and trastuzumab as primary systemic therapy for locally advanced HER2-positive breast cancer]. | 0 |
| 3 | 1 | |
| 4 | 18 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 1 | |
| 8 | 21 | |
| 9 | [A case of multi-drug resistant recurrent breast cancer with multiple bone metastasis responding to TS-1 and trastuzumab]. | 1 |
| 10 | 16 | |
| 11 | 4 | |
| 12 | [Key issues in sentinel node biopsy for breast cancer]. | 1 |
| 13 | 30 | |
| 14 | 265 | |
| 15 | 5 | |
| 16 | 2 | |
| 17 | 6 | |
| 18 | 16 | |
| 19 | 4 | |
| 20 | 1 |
About Naruhiko Mizuta
Naruhiko Mizuta is a scholar working on Cancer Research, Toxicology and Oncology, having authored 44 papers that have together received 683 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (13 papers), Cell death mechanisms and regulation (9 papers) and Breast Implant and Reconstruction (9 papers). The work is most often cited by research in Cancer Research (169 citations), Immunology (157 citations) and Pathology and Forensic Medicine (94 citations). Naruhiko Mizuta has collaborated with scholars based in Japan, South Korea and United States. Frequent co-authors include Ikuya Fujiwara, Hiroo Nakajima, Satoru Hashimoto, Yoshihiro Kitamura, Koichi Sakaguchi, Kunihiko Kooguchi, Atsuko Kobayashi, Junji Magae, Hiroshi Nakajima and Kiyoshi Sawai. Their work appears in journals such as Journal of Clinical Oncology, American Journal of Respiratory and Critical Care Medicine and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.